Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6
Interferons (IFNs) represent an important host defense against viruses. Type I IFNs induce JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral activity. Histone deacetylases (HDACs) perform multiple functions in regulating gene expression and some class I HDACs...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 116; no. 24; pp. 11997 - 12006 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
11.06.2019
|
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Interferons (IFNs) represent an important host defense against viruses. Type I IFNs induce JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral activity. Histone deacetylases (HDACs) perform multiple functions in regulating gene expression and some class I HDACs and the class IV HDAC, HDAC11, influence type I IFN signaling. Here, HDAC4, a class II HDAC, is shown to promote type I IFN signaling and coprecipitate with STAT2. Pharmacological inhibition of class II HDAC activity, or knockout of HDAC4 from HEK-293T and HeLa cells, caused a defective response to IFN-α. This defect in HDAC4−/− cells was rescued by reintroduction of HDAC4 or catalytically inactive HDAC4, but not HDAC1 or HDAC5. ChIP analysis showed HDAC4 was recruited to ISG promoters following IFN stimulation andwas needed for binding of STAT2 to these promoters. The biological importance of HDAC4 as a virus restriction factor was illustrated by the observations that (i) the replication and spread of vaccinia virus (VACV) and herpes simplex virus type 1 (HSV-1) were enhanced in HDAC4−/− cells and inhibited by overexpression of HDAC4; and (ii) HDAC4 is targeted for proteasomal degradation during VACV infection by VACV protein C6, a multifunctional IFN antagonist that coprecipitates with HDAC4 and is necessary and sufficient for HDAC4 degradation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 2Present address: Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, United Kingdom. Author contributions: Y.L., J.H.S., C.T.-C., S.A.-S., B.H., A.I.S., J.S.S., L.D., and G.L.S. designed research; Y.L., J.H.S., C.T.-C., S.A.-S., A.I.S., J.S.S., and L.D. performed research; Y.L., J.H.S., C.T.-C., S.A.-S., B.H., A.I.S., J.S.S., L.D., and G.L.S. analyzed data; and Y.L., J.H.S., C.T.-C., S.A.-S., A.I.S., L.D., and G.L.S. wrote the paper. 1Present address: Global Health Security Programme, Department of Health, SW1H 0EU London, United Kingdom. Edited by Thomas E. Shenk, Princeton University, Princeton, NJ, and approved April 25, 2019 (received for review September 27, 2018) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1816399116 |